Ingen Technologies, Inc. (IGNT)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 13, 2025
Ingen Technologies Company Description
Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States.
It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease.
The company was founded in 1999 and is based in Riverside, California.
Ingen Technologies, Inc.
| Country | United States |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5 |
| CEO | David Hanson |
Contact Details
Address: 3410 La Sierra Avenue Riverside, Georgia 92503 United States | |
| Phone | 951-688-7840 |
| Website | ingen-tech.com |
Stock Details
| Ticker Symbol | IGNT |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| ISIN Number | US45684G5080 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| David S. Hanson | Chief Executive Officer and Director |
| Gary B. Tilden | Chairman of the Board, Chief Operating Officer and Secretary |
| Richard O. Weed | General Counsel |